This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Berger K, Hessel F, Kreuzer J, Smala A, Diener HC.Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany. Current Medical Research and Opinion 24: 267-274, No. 1, Jan 2008
Rights and permissions
About this article
Cite this article
Clopidogrel beats aspirin for CV event prevention in Germany. Pharmacoecon. Outcomes News 545, 1 (2008). https://doi.org/10.2165/00151234-200805450-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805450-00001